BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25979286)

  • 1. The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing.
    Lietman TM; Gebre T; Abdou A; Alemayehu W; Emerson P; Blumberg S; Keenan JD; Porco TC
    Epidemics; 2015 Jun; 11():85-91. PubMed ID: 25979286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is declining.
    Rahman SA; West SK; Mkocha H; Munoz B; Porco TC; Keenan JD; Lietman TM
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003682. PubMed ID: 25815466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
    Keenan JD; Tadesse Z; Gebresillasie S; Shiferaw A; Zerihun M; Emerson PM; Callahan K; Cotter SY; Stoller NE; Porco TC; Oldenburg CE; Lietman TM
    PLoS Med; 2018 Aug; 15(8):e1002633. PubMed ID: 30106956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a single mass antibiotic distribution on the prevalence of infectious trachoma.
    Chidambaram JD; Alemayehu W; Melese M; Lakew T; Yi E; House J; Cevallos V; Zhou Z; Maxey K; Lee DC; Shapiro BL; Srinivasan M; Porco T; Whitcher JP; Gaynor BD; Lietman TM
    JAMA; 2006 Mar; 295(10):1142-6. PubMed ID: 16522834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Longitudinal Analysis of Chlamydial Infection and Trachomatous Inflammation Following Mass Azithromycin Distribution.
    Morberg DP; Alemayehu W; Melese M; Lakew T; Sisay A; Zhou Z; Cevallos V; Oldenburg CE; Porco TC; Lietman TM; Keenan JD
    Ophthalmic Epidemiol; 2019 Feb; 26(1):19-26. PubMed ID: 30153085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rationale for continuing mass antibiotic distributions for trachoma.
    Ray KJ; Porco TC; Hong KC; Lee DC; Alemayehu W; Melese M; Lakew T; Yi E; House J; Chidambaram JD; Whitcher JP; Gaynor BD; Lietman TM
    BMC Infect Dis; 2007 Aug; 7():91. PubMed ID: 17683646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community-level Association between Clinical Trachoma and Ocular Chlamydia Infection after MASS Azithromycin Distribution in a Mesoendemic Region of Niger.
    Amza A; Kadri B; Nassirou B; Cotter SY; Stoller NE; West SK; Bailey RL; Porco TC; Keenan JD; Lietman TM; Oldenburg CE
    Ophthalmic Epidemiol; 2019 Aug; 26(4):231-237. PubMed ID: 30957594
    [No Abstract]   [Full Text] [Related]  

  • 8. Complete local elimination of infectious trachoma from severely affected communities after six biannual mass azithromycin distributions.
    Biebesheimer JB; House J; Hong KC; Lakew T; Alemayehu W; Zhou Z; Moncada J; Rogér A; Keenan J; Gaynor BD; Schachter J; Lietman TM
    Ophthalmology; 2009 Nov; 116(11):2047-50. PubMed ID: 19744717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency of Mass Azithromycin Distribution for Ocular Chlamydia in a Trachoma Endemic Region of Ethiopia: A Cluster Randomized Trial.
    Lietman TM; Ayele B; Gebre T; Zerihun M; Tadesse Z; Emerson PM; Nash SD; Porco TC; Keenan JD; Oldenburg CE
    Am J Ophthalmol; 2020 Jun; 214():143-150. PubMed ID: 32171768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and associated factors of active trachoma among 1-9 years old children in Deguatemben, Tigray, Ethiopia, 2018: community cross-sectional study.
    Reda G; Yemane D; Gebreyesus A
    BMC Ophthalmol; 2020 Apr; 20(1):144. PubMed ID: 32293359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control.
    West SK; Munoz BE; Mkocha H; Gaydos C; Quinn T
    Ophthalmic Epidemiol; 2015; 22(3):170-5. PubMed ID: 26158574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can we stop mass drug administration prior to 3 annual rounds in communities with low prevalence of trachoma?: PRET Ziada trial results.
    Yohannan J; Munoz B; Mkocha H; Gaydos CA; Bailey R; Lietman TA; Quinn T; West SK
    JAMA Ophthalmol; 2013 Apr; 131(4):431-6. PubMed ID: 23392481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities.
    Wilson N; Goodhew B; Mkocha H; Joseph K; Bandea C; Black C; Igietseme J; Munoz B; West SK; Lammie P; Kasubi M; Martin DL
    Ophthalmic Epidemiol; 2019 Feb; 26(1):1-6. PubMed ID: 30543311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
    Ray KJ; Lietman TM; Porco TC; Keenan JD; Bailey RL; Solomon AW; Burton MJ; Harding-Esch E; Holland MJ; Mabey D
    PLoS Negl Trop Dis; 2009 Jun; 3(6):e458. PubMed ID: 19529761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-based coverage survey results following the mass drug administration of azithromycin for the treatment of trachoma in Amhara, Ethiopia.
    Astale T; Sata E; Zerihun M; Nute AW; Stewart AEP; Gessese D; Ayenew G; Melak B; Chanyalew M; Tadesse Z; Callahan EK; Nash SD
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006270. PubMed ID: 29451881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of oral azithromycin in clearing ocular chlamydia: mathematical modeling from a community-randomized trachoma trial.
    Liu F; Porco TC; Mkocha HA; Muñoz B; Ray KJ; Bailey RL; Lietman TM; West SK
    Epidemics; 2014 Mar; 6():10-7. PubMed ID: 24593917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete elimination is a difficult goal for trachoma programs in severely affected communities.
    Gill DA; Lakew T; Alemayehu W; Melese M; Zhou Z; House JI; Hong KC; Ray KJ; Gandhi N; Whitcher JP; Gaynor BD; Lietman TM
    Clin Infect Dis; 2008 Feb; 46(4):564-6. PubMed ID: 18194094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical activity and polymerase chain reaction evidence of chlamydial infection after repeated mass antibiotic treatments for trachoma.
    Keenan JD; Lakew T; Alemayehu W; Melese M; Porco TC; Yi E; House JI; Zhou Z; Ray KJ; Acharya NR; Whitcher JP; Gaynor BD; Lietman TM
    Am J Trop Med Hyg; 2010 Mar; 82(3):482-7. PubMed ID: 20207878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coverage of azithromycin mass treatment for trachoma elimination in Northwestern Ethiopia: a community based cross-sectional study.
    Tilahun Z; Fenta TG
    BMC Ophthalmol; 2018 Aug; 18(1):193. PubMed ID: 30081851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction and return of infectious trachoma in severely affected communities in Ethiopia.
    Lakew T; House J; Hong KC; Yi E; Alemayehu W; Melese M; Zhou Z; Ray K; Chin S; Romero E; Keenan J; Whitcher JP; Gaynor BD; Lietman TM
    PLoS Negl Trop Dis; 2009; 3(2):e376. PubMed ID: 19190781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.